Hyperhomocysteinemia and hyperlipidemia in coronary heart disease

Chinese Medical Journal

Volumn 112, Issue 7, 1999, Pages 586-589

  Gao, Wei ^a   Jiang, Ning ^a   Meng, Zhaoheng ^b   Tang, Jian ^b  

^a First Teaching Hospital   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Coronary heart disease; Folate; Homocysteine; Risk factor

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

ADULT; AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GENETICS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; MALE; MIDDLE AGED; POINT MUTATION; RISK FACTOR;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADULT; AGED; CORONARY DISEASE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES; POINT MUTATION; RISK FACTORS; VITAMIN B 12;

EID: 0033157264     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Susan C, Louis M, Fonseca V. Hyperhomocysteinemia - an emerging and important risk factor for thromboembolic and cardiovascular disease. Clin Chem 1996;106:709-722.
2. Andrzej J. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 1993;14:683-693.
3. Skovby F. Inborn errors of metabolism causing homocysteinemia and related vascular involvement. Haemostasis 1989;19(Suppl 1):4-9.
4. Ueland PM, Refsum H, Stable SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-1779.
5. Svardal M. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989;35:1921-1927.
6. 6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993;57:47-53.
7. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and Intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
8. Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996;94:2410-2415.
9. Kluijtmans LAG, Heuvel LP, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia: common mutation in the methylenetetrhydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.
10. Tsai MY, Bignell M, Schwichtenberg K, et al. High prevalence of a mutation in the cystathionine β-synthase gene. Am J Hum Gent 1996;59:1262-1267.